<SEC-DOCUMENT>0000731766-22-000016.txt : 20220414
<SEC-HEADER>0000731766-22-000016.hdr.sgml : 20220414
<ACCEPTANCE-DATETIME>20220414060226
ACCESSION NUMBER:		0000731766-22-000016
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220414
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220414
DATE AS OF CHANGE:		20220414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		22825908

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>unh-20220414.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:cca5920e-4dbb-4757-838b-577d98b01fbe,g:3474f77a-31b3-40f0-aed1-cd474a16ba6f,d:cdcf62dff6694f9c960f285ee1ee3ec3--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>unh-20220414</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM180L2ZyYWc6NWI0NjgzZGQzNTFiNGYwYjk3ZmI1YWY3NzM0MmNjYzQvdGFibGU6ODFkOTIzZjJmMDFjNGI3MWIwZjVjMTM5MmUzNGI0YmEvdGFibGVyYW5nZTo4MWQ5MjNmMmYwMWM0YjcxYjBmNWMxMzkyZTM0YjRiYV8yLTEtMS0xLTI0NTgy_1f39ed76-9a92-4c29-be2a-152bfae4e568">0000731766</ix:nonNumeric><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM180L2ZyYWc6NWI0NjgzZGQzNTFiNGYwYjk3ZmI1YWY3NzM0MmNjYzQvdGFibGU6ODFkOTIzZjJmMDFjNGI3MWIwZjVjMTM5MmUzNGI0YmEvdGFibGVyYW5nZTo4MWQ5MjNmMmYwMWM0YjcxYjBmNWMxMzkyZTM0YjRiYV8zLTEtMS0xLTI0NTgy_d03301a8-9d6c-4622-a736-54d3ee32928e">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="unh-20220414.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-14</xbrli:startDate><xbrli:endDate>2022-04-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icdcf62dff6694f9c960f285ee1ee3ec3_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg3_5b3d6f6f-bd41-491a-9648-73e47c0c42aa">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Current Report </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8yNTc_983e7115-1eaa-489c-a36e-8432b105bde9">April 14, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg0_d80100cb-d9bb-45cf-b5dc-e81ec0fd5140">UNITEDHEALTH GROUP INCORPORATED</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:15.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTAtMS0xLTI0NTgy_b723c78e-33a9-4729-ad6f-5c359977aa0a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTItMS0xLTI0NTgy_25eecbb2-2b98-480c-b641-796b63ecd3db">1-10864</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTQtMS0xLTI0NTgy_9bb48c38-16d8-4abe-8c02-75244012a1bf"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTQtMS0xLTI0NTgy_b25ba955-33e3-43d3-9d5b-c00c9cd4a459">41-1321939</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission File Number)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:59.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTAtMS0xLTI0NTgy_d1244ec9-8d29-4c86-8276-18ce42fd6a93">UnitedHealth Group Center, 9900 Bren Road East,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTEtMS0xLTI0NTgy_4e549972-f60e-4b90-bb73-b87292df6b06">Minnetonka,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTItMS0xLTI0NTgy_0c84dd60-cffd-40d7-b93c-17774fd21db5">Minnesota</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTMtMS0xLTI0NTgy_765b8c53-f5fb-4cdf-b258-20b08d65a225">55343</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg4_78a23195-45d9-46a3-9e5c-8d57705a21d6">952</ix:nonNumeric>) <ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg5_97af04e8-4164-4771-a1a4-a0201f65fe7c">936-1300</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjkw_4e7eef3e-099f-4d9c-9f50-0f61621e9205">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg1_79506bb7-90da-48b0-a3f3-3629b0b8facd">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg2_f591d502-a81e-45b2-b2bb-feb106222a26">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjkx_53c1b9b9-f87d-4287-9513-ea61cf82bbc8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:33.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTAtMS0xLTI0NTgy_701e197a-0ede-4758-9538-9360cc6b47bf">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTItMS0xLTI0NTgy_88485718-76ab-4745-9726-d51463cfe46b">UNH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTQtMS0xLTI0NTgy_a0d15fc0-e87b-495e-83c2-7943fa6e039f">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjky_8c77cb27-6265-4c02-ba8d-1a16405003b6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icdcf62dff6694f9c960f285ee1ee3ec3_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations and Financial Condition.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 14, 2022, UnitedHealth Group Incorporated (the &#8220;Company&#8221;) issued a press release announcing its first quarter 2022 results.  A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022q1exhibit991.htm">99.1</a></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022q1exhibit991.htm">Press Release dated April 14, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: April 14, 2022 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Kuai H. Leong</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kuai H. Leong</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assistant Secretary</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a2022q1exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1e4554645d2941afb24852dfad4e7a1c_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><img alt="uhglogo2019a02.jpg" src="uhglogo2019a02.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:352px"></div><div><font><br></font></div><div style="margin-top:45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UnitedHealth Group Reports First Quarter 2022 Results</font></div><div style="margin-top:12pt;padding-left:360pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Revenues of $80.1 Billion Grew $10 Billion or 14% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare</font></div><div style="margin-top:9pt;padding-left:360pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Earnings from Operations were $7 Billion</font></div><div style="margin-top:9pt;padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Cash Flows from Operations were $5.3 Billion</font></div><div style="margin-top:9pt;padding-left:360pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Earnings were $5.27 Per Share, Adjusted Earnings $5.49 Per Share</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">MINNETONKA, Minn. (April 14, 2022) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8211; Strong and well-balanced growth continued across UnitedHealth Group (NYSE&#58; UNH) in the first quarter of 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8220;Disciplined execution of our long-term strategy, with a sharp focus on ensuring access to care for the people we serve, enabled us to deliver high-quality, diversified growth across Optum and UnitedHealthcare during this first quarter of 2022,&#8221; said Andrew Witty, chief executive officer of UnitedHealth Group.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Based upon the first quarter performance and enterprise-wide growth outlook, the Company increased its full year net earnings outlook to $20.30 to $20.80 per share and adjusted net earnings to $21.20 to $21.70 per share. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 1 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="uhglogo2019a02.jpg" src="uhglogo2019a02.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:304px"></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:330.75pt"><tr><td style="width:1.0pt"></td><td style="width:117.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80.1 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.2 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$73.7 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 7.0 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 6.7 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 5.5 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">UnitedHealth Group&#8217;s first quarter 2022 revenues grew $10 billion or 14.2% to $80.1 billion year-over-year, including diversified, double-digit growth at both Optum and UnitedHealthcare.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">First quarter 2022 earnings from operations were $7 billion and adjusted net earnings were $5.49 per share. Year-over-year earnings growth was led by Optum Health, due to its positive impact for patients and the accelerating expansion of its value-based care delivery initiatives.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">The first quarter 2022 medical care ratio was 82% compared to 80.9% last year, due to COVID effects and business mix. Favorable medical reserve development of $290 million compared to $1 billion in the year ago first quarter. Days claims payable were 49.1, compared to 46.8 in the fourth quarter 2021 and 49.8 in the first quarter 2021.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">The first quarter 2022 operating cost ratio of 14.2% decreased from 14.6% in 2021 due to COVID effects and continued productivity advances, partially offset by business mix and the investments the Company continues to make to accelerate and support future growth opportunities.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Cash flows from operations for the first quarter 2022 were $5.3 billion or 1-times net income. The Company returned $3.9 billion to shareholders in the first quarter through dividends and share repurchases. Return on equity of 27.8% in the quarter reflected the Company&#8217;s consistent and diverse earnings profile and efficient capital structure.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="uhclogo.jpg" src="uhclogo.jpg" style="height:67px;margin-bottom:5pt;vertical-align:text-bottom;width:368px"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience and reducing the total cost of care.</font></div><div style="margin-bottom:1pt;margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:348.75pt"><tr><td style="width:1.0pt"></td><td style="width:118.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62.6 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55.1 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56.4 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 3.8 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 4.1 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 2.1 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">UnitedHealthcare first quarter revenues of $62.6 billion grew $7.5 billion or 13.6% year-over-year reflecting broad-based growth.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">In the first quarter of 2022, UnitedHealthcare grew to serve 1.5 million more people than a year ago, led by continued strong growth in Medicare Advantage and Dual Special Needs Plans and in the broader Medicaid market. UnitedHealthcare&#8217;s expanding portfolio of innovative, new offerings for people served by commercial benefits, including physician-led, consumer-tailored and virtual-first products, grew by 350,000 people over the past year. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">First quarter 2022 operating earnings were $3.8 billion compared to $4.1 billion last year, reflecting strong growth in people served and revenue, and continued effective medical and operating cost management. The year ago result reflects the effects of pandemic-disrupted care patterns. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 3 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="optumlogo.jpg" src="optumlogo.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"></div><div style="margin-bottom:15pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Optum&#8217;s health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics, technology and clinical insights, Optum helps improve overall health system performance&#58; optimizing care quality, reducing care costs and improving the consumer experience.</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:342.75pt"><tr><td style="width:1.0pt"></td><td style="width:112.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly Financial Performance</font></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</font></td><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$43.3 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.4 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.1 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 3.2 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 2.6 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 3.4 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Optum first quarter revenues grew 18.9% to $43.3 billion and operating earnings grew 19.8% to $3.2 billion.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Optum Health revenue per consumer served increased 33% over the year ago quarter, driven by growth of people served under value-based care arrangements. Optum Health now expects to serve 600,000 new patients under such arrangements in 2022 compared to its initial outlook of 500,000. The results reflect the continued expansion of care services offered, with at-home and digital offerings complementing and integrating with growing clinic-based and outpatient services, including ambulatory surgical care. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Optum Insight&#8217;s revenue backlog increased by $2 billion to $22.8 billion compared to a year ago, driven by strong growth and execution in its expanding comprehensive managed services offerings for health systems. The breadth of services offered by Optum Insight continues to advance in areas such as payment integrity, digital modernization and care coordination. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:14.5pt">Optum Rx&#8217;s robust revenue growth of 11% in the first quarter reflects continued advancements in serving new, large health plan clients and further expansion of community-behavioral, specialty pharmacy and e-commerce services. Adjusted scripts grew to 352 million compared to 329 million last year.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 4 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">About UnitedHealth Group</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">UnitedHealth Group (NYSE&#58; UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> and follow </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">&#64;UnitedHealthGrp</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> on Twitter.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Earnings Conference Call</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">As previously announced, UnitedHealth Group will discuss the company&#8217;s results, strategy and future outlook on a conference call with investors at 8&#58;45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company&#8217;s website (</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">). Following the call, a webcast replay will be available on the same site through April 28, 2022. The conference call replay can also be accessed by dialing 1-888-203-1112, Conference Code&#58; 3063505. This earnings release and the Form 8-K dated April 14, 2022, can also be accessed from the Investor Relations page of the Company&#8217;s website.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Non-GAAP Financial Information</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%;text-decoration:underline">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">The statements, estimates, projections, guidance or outlook contained in this document include &#8220;forward-looking&#8221; statements which are intended to take advantage of the &#8220;safe harbor&#8221; provisions of the federal securities law. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including&#58; risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic&#59; our ability to effectively estimate, price for and manage medical costs&#59; new or changes in existing health care laws or regulations, or their enforcement or application&#59; the DOJ&#8217;s legal action relating to the risk adjustment submission matter&#59; our ability to maintain and achieve improvement in quality scores impacting</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 5 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">revenue&#59; reductions in revenue or delays to cash flows received under government programs&#59; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits&#59; failure to maintain effective and efficient information systems or if our technology products do not operate as intended&#59; cyberattacks, other privacy&#47;data security incidents, or our failure to comply with related regulations&#59; failure to protect proprietary rights to our databases, software and related products&#59; risks and uncertainties associated with our businesses providing pharmacy care services&#59; competitive pressures, including our ability to develop and deliver innovative products to health care payers and expand access to virtual care&#59; changes in or challenges to our public sector contract awards&#59; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers&#59; failure to attract, develop, retain, and manage the succession of key employees and executives&#59; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations)&#59; failure to achieve targeted operating cost productivity improvements&#59; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews&#59; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions&#59; fluctuations in foreign currency exchange rates&#59; downgrades in our credit ratings&#59; our investment portfolio performance&#59; impairment of our goodwill and intangible assets&#59; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># # #</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investor Contact&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zack Sopcak</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952-936-7215</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">zack.sopcak&#64;uhg.com</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media Contact&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matt Stearns</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202-276-0085</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">matt.stearns&#64;uhg.com</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 6 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i1e4554645d2941afb24852dfad4e7a1c_4"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Earnings Release Schedules and Supplementary Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Quarter Ended March&#160;31, 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Operations</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Balance Sheets</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Cash Flows</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Businesses</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Business Metrics</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Reconciliation of Non-GAAP Financial Measure</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1e4554645d2941afb24852dfad4e7a1c_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$64,070</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,486</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,340</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,340</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,918</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,149</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,196</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,523</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,904</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,401</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,223</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,487</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,572</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,199</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,457</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,950</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,739</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,517</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,342</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,369)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,364)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,148</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,978</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,027</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,862</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share attributable to UnitedHealth Group common shareholders </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.27</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.08</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.49</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.31</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">See page 6 for a reconciliation of the non-GAAP measure</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">March 31,<br>2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,<br>2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash and short-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$28,396</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$23,907</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,871</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,216</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,762</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23,635</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69,029</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61,758</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42,353</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43,114</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">109,856</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">107,334</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$221,238</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$212,206</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Medical costs payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$28,676</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$24,483</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,697</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,620</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,797</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50,189</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88,170</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">78,292</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,796</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42,383</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,625</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,052</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,519</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,434</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76,128</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75,045</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$221,238</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$212,206</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,148</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,978</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in operating assets and liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,094)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,319</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,005</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Purchases of investments, net of sales and maturities</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,632)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,714)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,673)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,707)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,500)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,650)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,363)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in short-term borrowings and long-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,921</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,482</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,955</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except percentages)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62,595</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,114</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,259</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,384</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,705)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,302)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80,149</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70,196</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,798</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,108</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum (a)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,152</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated earnings from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,950</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,739</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating margin</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Domestic</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,822</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,632</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,035</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Total</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,955</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,667</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Medicare &#38; Retirement</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,100</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,474</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community &#38; State</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,540</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,973</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16,682</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,403</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insight</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,219</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rx</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,911</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,604</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum eliminations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Earnings from operations for Optum for the three months ended March 31, 2022 and 2021 included $1,366 and $962 for Optum Health&#59; $847 and $779 for Optum Insight&#59; and $939 and $890 for Optum Rx, respectively.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTHCARE CUSTOMER PROFILE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in thousands)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">People Served</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - Domestic&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,950&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,985&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,860&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-based</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,460&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,595&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,455&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total Commercial - Domestic</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,410&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,580&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,315&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,490&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,810&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,655&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement (Standardized)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,390&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total Community and Senior</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,055&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,540&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,700&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Domestic Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,465&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,120&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,015&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,510&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,965&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,475&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Medicare Part D stand-alone</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,795&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTUM PERFORMANCE METRICS</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Consumers Served (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insight Contract Backlog (in billions)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.8</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rx Quarterly Adjusted Scripts (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note&#58; UnitedHealth Group served 148 million unique individuals across all businesses at March 31, 2022.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECONCILIATION OF NON-GAAP FINANCIAL MEASURE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADJUSTED NET EARNINGS PER SHARE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.921%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected <br>Year Ended <br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,027</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,862</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,250 - $19,825</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;1,130</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of intangible amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;(280)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,239</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,085</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,100 - $20,675</font></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted earnings per share</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.27</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.08</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.30 - $20.80</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;1.20</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect per share of intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#126;(0.30)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted diluted earnings per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.49</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.31</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.20 - $21.70</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company&#8217;s acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company&#8217;s revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>unh-20220414.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cca5920e-4dbb-4757-838b-577d98b01fbe,g:3474f77a-31b3-40f0-aed1-cd474a16ba6f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:unh="http://www.unitedhealthgroup.com/20220414" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.unitedhealthgroup.com/20220414">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20220414_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20220414_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20220414_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.unitedhealthgroup.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>unh-20220414_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cca5920e-4dbb-4757-838b-577d98b01fbe,g:3474f77a-31b3-40f0-aed1-cd474a16ba6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20220414.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended" id="ie28a5293f8c14de886f350994b1c6d70_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_58ffb7e4-3028-46ef-ad45-36976fc177dd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_DocumentType_58ffb7e4-3028-46ef-ad45-36976fc177dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f583d005-a8b2-4b28-be30-26b6088884b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_DocumentPeriodEndDate_f583d005-a8b2-4b28-be30-26b6088884b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_691080ec-564a-487a-b1d5-6585f5c2746e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityRegistrantName_691080ec-564a-487a-b1d5-6585f5c2746e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_860bee3f-f751-4737-8d8b-25bad5235130" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityIncorporationStateCountryCode_860bee3f-f751-4737-8d8b-25bad5235130" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bd62a52d-01b8-45ee-9b95-9c3dfd967a77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityFileNumber_bd62a52d-01b8-45ee-9b95-9c3dfd967a77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7e90cc17-b98e-4069-96fb-d5502b61f87f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityTaxIdentificationNumber_7e90cc17-b98e-4069-96fb-d5502b61f87f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f85f11b5-4eab-4b07-9112-3b206b19caf7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressAddressLine1_f85f11b5-4eab-4b07-9112-3b206b19caf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2295b124-8dde-4c55-8bb5-67a5cf01ef1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressCityOrTown_2295b124-8dde-4c55-8bb5-67a5cf01ef1f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6b313bee-2c1d-43b3-bbb5-7e5f750baaef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressStateOrProvince_6b313bee-2c1d-43b3-bbb5-7e5f750baaef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3ce474a0-03a7-4695-9723-ed99d8ead097" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressPostalZipCode_3ce474a0-03a7-4695-9723-ed99d8ead097" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dec24391-3d44-4d27-b296-4a86086bf443" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_CityAreaCode_dec24391-3d44-4d27-b296-4a86086bf443" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_925dcd9e-12e6-4c0b-8665-3dcdb6127a3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_LocalPhoneNumber_925dcd9e-12e6-4c0b-8665-3dcdb6127a3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_427651a8-0618-4c13-a1d0-2cabd81d3ee3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_WrittenCommunications_427651a8-0618-4c13-a1d0-2cabd81d3ee3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_73d08e43-b655-4e7e-a345-bdfaf06a14b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_SolicitingMaterial_73d08e43-b655-4e7e-a345-bdfaf06a14b1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9da789ca-2d0e-4af6-8688-d65005399575" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_PreCommencementTenderOffer_9da789ca-2d0e-4af6-8688-d65005399575" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_20441781-268f-41e6-93b8-3a0c53d40bec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_20441781-268f-41e6-93b8-3a0c53d40bec" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0df15812-acb7-4053-8663-0f206d1b6b7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_Security12bTitle_0df15812-acb7-4053-8663-0f206d1b6b7e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc3a1ccf-0f44-451c-aa2a-29ed14638585" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_TradingSymbol_fc3a1ccf-0f44-451c-aa2a-29ed14638585" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_76ea6581-55df-45f8-bcf8-009a9af1d90a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_SecurityExchangeName_76ea6581-55df-45f8-bcf8-009a9af1d90a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f74c1d61-4e9a-4f7e-8439-38f56c19b2cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityEmergingGrowthCompany_f74c1d61-4e9a-4f7e-8439-38f56c19b2cf" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0bdbbfa8-2057-4ef8-93af-640215f8e61b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityCentralIndexKey_0bdbbfa8-2057-4ef8-93af-640215f8e61b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4b0bdb87-728f-44af-a56d-c8db5f1fc865" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_AmendmentFlag_4b0bdb87-728f-44af-a56d-c8db5f1fc865" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:to="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_4aa9c1d4-fbc4-424d-8f75-c484fdee9840_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:to="loc_dei_DocumentDomain_4aa9c1d4-fbc4-424d-8f75-c484fdee9840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_b52cb354-0cb5-4cea-b6d0-b123e460f680" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:to="loc_dei_DocumentDomain_b52cb354-0cb5-4cea-b6d0-b123e460f680" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>unh-20220414_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cca5920e-4dbb-4757-838b-577d98b01fbe,g:3474f77a-31b3-40f0-aed1-cd474a16ba6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_38f86d6a-4804-4295-8f5b-6a9b37adfee2_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_298212d5-d224-4cf1-a86a-4cc6c136102a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_8abce6e8-a115-48e5-971e-34394c8f31c0_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6e5586d3-b2c4-4457-ad35-3eccd7c62ceb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_37771bdb-3080-41e5-b90b-25571892e5cd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_47f088e8-9b33-4d10-9d54-187bea9dc696_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_86956c69-dc9e-44d4-8165-0f65eea6e423_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3755e2af-beee-4769-9dc6-e5713035c565_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_33e044b0-45c9-4696-9149-5e16a558ade0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3599567b-0e1f-49e0-a545-58718abf5fa8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_536789a6-03b5-4249-ad65-fe2990ae0f62_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c39afa5d-a7ac-4199-a723-12bf709e6548_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6f8a7792-d7cd-4034-964f-003ee157c8cf_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f7b751f2-c1a3-422f-a66e-f9c398ca99f5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_5abca995-f31a-4d08-8c20-c11b19e225c3_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6889fffa-6539-4ec2-883c-a0cddd404be0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8e139745-42f5-4e1b-bfe9-3ee198040a93_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_31dafee6-a7cf-4a0d-9112-ea82fbeb2ae6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_18fbff74-fb85-4080-8b80-f63794469421_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_634da193-165a-4996-8e7f-c491122d468a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_855cec90-9391-4d93-9b93-8609634d1a90_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a896cb66-5b22-46b5-a8c0-ab082caeb839_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_e4b519db-fa92-4ce2-b367-4b1903ba5f33_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e4b0225b-ed67-40ca-964a-ca9c15178a9c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_379874e5-b4ed-4991-ae4b-c6bd7e55952d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8fcba24b-c122-4b93-a726-b6dda317d45d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>unh-20220414_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cca5920e-4dbb-4757-838b-577d98b01fbe,g:3474f77a-31b3-40f0-aed1-cd474a16ba6f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20220414.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8074b59b-7715-49ce-915a-1a9fe161b51e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8074b59b-7715-49ce-915a-1a9fe161b51e" xlink:to="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:to="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_b52cb354-0cb5-4cea-b6d0-b123e460f680" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_4aa9c1d4-fbc4-424d-8f75-c484fdee9840" xlink:to="loc_dei_DocumentDomain_b52cb354-0cb5-4cea-b6d0-b123e460f680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1d40d506-fc5d-4c3d-b903-e9b61bbdf41c" xlink:to="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_58ffb7e4-3028-46ef-ad45-36976fc177dd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_DocumentType_58ffb7e4-3028-46ef-ad45-36976fc177dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f583d005-a8b2-4b28-be30-26b6088884b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_DocumentPeriodEndDate_f583d005-a8b2-4b28-be30-26b6088884b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_691080ec-564a-487a-b1d5-6585f5c2746e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityRegistrantName_691080ec-564a-487a-b1d5-6585f5c2746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_860bee3f-f751-4737-8d8b-25bad5235130" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityIncorporationStateCountryCode_860bee3f-f751-4737-8d8b-25bad5235130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bd62a52d-01b8-45ee-9b95-9c3dfd967a77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityFileNumber_bd62a52d-01b8-45ee-9b95-9c3dfd967a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7e90cc17-b98e-4069-96fb-d5502b61f87f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityTaxIdentificationNumber_7e90cc17-b98e-4069-96fb-d5502b61f87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f85f11b5-4eab-4b07-9112-3b206b19caf7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressAddressLine1_f85f11b5-4eab-4b07-9112-3b206b19caf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2295b124-8dde-4c55-8bb5-67a5cf01ef1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressCityOrTown_2295b124-8dde-4c55-8bb5-67a5cf01ef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6b313bee-2c1d-43b3-bbb5-7e5f750baaef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressStateOrProvince_6b313bee-2c1d-43b3-bbb5-7e5f750baaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3ce474a0-03a7-4695-9723-ed99d8ead097" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityAddressPostalZipCode_3ce474a0-03a7-4695-9723-ed99d8ead097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dec24391-3d44-4d27-b296-4a86086bf443" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_CityAreaCode_dec24391-3d44-4d27-b296-4a86086bf443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_925dcd9e-12e6-4c0b-8665-3dcdb6127a3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_LocalPhoneNumber_925dcd9e-12e6-4c0b-8665-3dcdb6127a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_427651a8-0618-4c13-a1d0-2cabd81d3ee3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_WrittenCommunications_427651a8-0618-4c13-a1d0-2cabd81d3ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_73d08e43-b655-4e7e-a345-bdfaf06a14b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_SolicitingMaterial_73d08e43-b655-4e7e-a345-bdfaf06a14b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9da789ca-2d0e-4af6-8688-d65005399575" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_PreCommencementTenderOffer_9da789ca-2d0e-4af6-8688-d65005399575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_20441781-268f-41e6-93b8-3a0c53d40bec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_20441781-268f-41e6-93b8-3a0c53d40bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0df15812-acb7-4053-8663-0f206d1b6b7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_Security12bTitle_0df15812-acb7-4053-8663-0f206d1b6b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc3a1ccf-0f44-451c-aa2a-29ed14638585" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_TradingSymbol_fc3a1ccf-0f44-451c-aa2a-29ed14638585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_76ea6581-55df-45f8-bcf8-009a9af1d90a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_SecurityExchangeName_76ea6581-55df-45f8-bcf8-009a9af1d90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f74c1d61-4e9a-4f7e-8439-38f56c19b2cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityEmergingGrowthCompany_f74c1d61-4e9a-4f7e-8439-38f56c19b2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0bdbbfa8-2057-4ef8-93af-640215f8e61b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_EntityCentralIndexKey_0bdbbfa8-2057-4ef8-93af-640215f8e61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4b0bdb87-728f-44af-a56d-c8db5f1fc865" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_61d01c96-62ec-49fd-bf09-8128c2361b10" xlink:to="loc_dei_AmendmentFlag_4b0bdb87-728f-44af-a56d-c8db5f1fc865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>optumlogo.jpg
<TEXT>
begin 644 optumlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-I;7!S;VXL
M($UA<F-U<R!*   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,P
M-   DI(  @    ,P-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M( Y.*;O3^\OYT .HI RDX# _C2T %%%% !1110 4444 %%%% !1110 4444
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M.O@YPI[_ .3N>Q44R&>*YA66WD62-AD,AR#5+6-;L]$L7N+R4 @?)&#\SGT
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MM@RRWK->2KSAAA ?IWKK418T"HH55&  , 5ZN%RMI\U;[CY_'Y_%Q=/"_?\
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>uhclogo.jpg
<TEXT>
begin 644 uhclogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-I;7!S;VXL
M($UA<F-U<R!*   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,P
M,@  DI(  @    ,P,@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(O$NOL<Q@GV _)(.J\C^596;5R[FC1112 **** "BBN9\:^(-=\/6,5SX?\
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M(_\ L%7/_HIJ^<O@9J%GH7Q4*:M=16OF6\MLKR, IDW*0,GCG:<>IP.]>_\
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M=.*J_=:QO3C34GR$]%%%<1N%%%% 'G7Q,^'/AWQ*HU/4;#4!=1J=]SI:AI6
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MO3[D:Y(4>PR?SKI**?MJG\S^\.2/8Y+_ (59X'_Z%FP_[X/^-;\NBZ=-H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>uhglogo2019a02.jpg
<TEXT>
begin 644 uhglogo2019a02.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
MJ]<=6T_\)//^R-?D=_XLW-_[ZOK[W'_O[_RLEG_SP_\ 663H>^Q7_*NWG_/;
M_P!8H^MJ'W!'4W]:D_\ PJ1^#^T-P])[,^=.SMOX_%]C==[JP'7/;^4H*6*D
MFW?UUNT/BMHYC/S1K_N0R^RMVQ4>.I)&7S/0YAHY)&CI::-,@?8OFBXAW.7E
M:Y<M9S1M)"":Z)$RX7T#I5B.&I*@59B8&][>6K>;;8^9[= MY"ZQRD"FN-L(
M6]2C44>='H310.JA_P#A,W\F<QTY_,)I>E*C)RQ;&^46QMQ[.RF+EE9,<-\;
M$P^5[!V+GW12 <E34N(RV)I[W4C-N"-10K(7O9LD>X\H'<PO^-6,JN#YZ)"(
MW7["2CG_ $@Z /LUO4FW\V#;2W^+7L3(1Y:T!D1OMH&4?Z<]?10]X>=9;]?'
MO^1__90_?/\ XF?M'_WN,Y[Z)[-_R1[3_GFB_P".+US^WC_DK77_ #TR?\?;
MKZ+_ /+.^>7P;V'_ "^OAOLO?/S-^*&S-X[7^._6&$W+M/=GR)ZAV[N7;N9Q
M^V*&GK\1G<%F-X4>4Q.3HIT*34]1%'+&X(901;WASSMRIS1=\W;E<VNVW\MM
M)>2LKI;S,K*6-"K!""#Y$&AZRYY-YHY9M>5-NMKG<;&.X2TC#*UQ$K*0HJ&4
MN""/,$5Z/%_PX_\ R\?^\\_AA_Z5'T?_ /9S["_]3.</^C3N7_9+/_T!T)OZ
MX<I?]'3;O^RF'_H/K6%_X4[_ "A^,_?O1/Q?Q'1/R)Z+[JRVW^VMX9+/8OJ7
MMO8'8^1PF.JMG0TM-7Y>BV=N#,U.-HJBI!C26941W]()/'N</8_8M[VG=;Z3
M=;.ZMHWMT"F6*2,,0]2 74 FGD.H6]Z=[V;==KLH]KN[6YD2=RPBE20@%*5(
M1B0*^9Z)]_PE*_[>'=R_^*8=A_\ O\/CK[$7OW_RI]M_TLH_^K%QT'O8S_E;
M;C_I72?]7K?KZ!7O$CK*SKXQ'OI+USMZ^P?\;_\ LG?H7_Q"_5O_ +P^"]\[
M=Z_Y+%W_ ,],O_'VZZ [/_R2;7_GFB_XXO0T>RSHQZ][]U[KWOW7NM+[_A6-
M\F9#/\9?A]AJ]EB2+,?(??\ 1)(A6621\IU[U?J"-Y%:!8]TO(C@*WDA87(N
M,D_8'9!2^YBD&<6\9_9)+_UB_GUCK[[;R:V7+\9QF>0?MCC_ .LO\NJ],!_+
MK6I_X3O[O^5TF MV34?)7&]\8[(?:R1Y>7I+;%94_'M\&8YF4C&)G,YE=QM*
M%'EI8HG6Z*"PPFYQT^\$>P!_\2%D8"*X\9@+C5]NE5CIY$D=!.+E&OM+)OI3
M_'#>"<'S\%3X%/LU,TGS !Z"O_A.M\FT^/7\RCKS:^7KDH]H?)+;^;Z'S1G8
MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
MM8-LO?%K0ZXGC4'^D\@55_VQ'4V7?.O*5E;FYGW*S\*E>V5)&/\ I50LS?[4
M'KYZO\X?^9#/_,F^4K]@;;QN5V[TEUK@WV%TMMS-"*+,R8/[Z3(9S>FX:6":
MHIJ/<6]<HRRR01.ZTM!34=,S220/-+EY[=<F#DO8OI)F5]SG;Q)F7AJI144\
M2J#%3Q8LV 0!B=[@\X'G'>_JX0R;;"NB%3QTUJSL/)G.:>2A1D@D[?7_  G3
M_E[[F^'?Q6W!W%VS@I\!W-\I*K;NZ*C;V2I1!F-F=5;>I<@>O,%DHI&EFH,U
MG7SM;F*Z&\4B15='3U$25%(X7'GWBYO@YCWY-NV]P^VV 9=0.'E8CQ&'JJZ5
M13G(8@T8=3][1\IS<O[&^X7ZE-QOBK:2,I$H/AJ?0MJ+D8P5!%5ZL3_FI_%#
M+?-3X%_(/H+:T$-1OW.;8H=T=;1330TPJ=_]?YS&;UVWB%JZEDI:+^]%3@SB
M'FE(CBBKW9BH&H [D/?X^6>:[/=IR1:(Y63SI'(I1C09.D-KH,DKT+N>-BDY
MCY7N]J@ -TR!H_\ 3QL'45X#45T5/ -U\T'XG=Z;O^#7S#ZC[OKMJ9)=S] ]
MJP5.\-AYB"?!YR6DQ=95[;[#V560UT*5&"S]3@ZG(8^\\1:BJV#21-H9#FOO
M^U6_-/+EQM:R+X%W;T20=RU(#1N*?$H8*V#D<#FO6&VQ;G<<L\P6^Y-&WC6L
M_>A[6H"5D0U^%BNI<C!XC%.OI>=)_P US^7=WSL/&[^VC\NNC-O4M9BERN2V
MOV=V1M'J_?FUA'%&V0I=S[/WOF<-E\><5.YAEJ8TFQ\K*7IZF:(I(V%&Y\@\
MX;5=M:7&WW3L&H&BC>6-O0JZ @UX@88>:@XZS)VWGKE+=+5;JWO[9%*U*R2)
M&Z^H9'((IP)RI\B1GK7=_P"%#'\WKXW=M?'6?X6?%_LK =RY3L#=FU\QW!O?
M8]8,UU[@MH;'S%)NS$;:Q>ZZ4C#;ISV<WEB\95^3&S5M'2TM!*DKB:6,),/M
M![>;UM^\#F7?('MHX8V$*.-,C.X*%BARJJA848 DL*"@/42>[//^SW^T'ES9
M)DN'ED4RNAK&J(0P4,,,S.%/:2 %-34CHM7_  EI^'N\-W_([?GS/SF%JZ+K
M+J':&X>M]E9NH@>*FW%VKO:GQU/F*;$3LP6KBVEL.HJ17V4B.3,4@O<L =>^
MO,5M;[-%RU$P-]<2+(Z^:Q)6A/IKDII^2-T3>R/+]Q<;Q+S%*I%E;QM&A_BE
M>E0/72E=7^G7K<F^;'_9&?RW_P#%8^^O_?5[K]XX\L_\K)M__/=!_P!74ZR&
MYD_Y5V__ .>*?_JTW7RB_CA_V4/T-_XF?J[_ -[C!^\]]Y_Y(]W_ ,\TO_'&
MZP8V?_DK6O\ STQ_\?7K["'OG9UT!Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZXLJNK(ZJZ.I5E8!E96%F5E
M-P5(-B#[]PZ]QP>M?WY=_P#";_X"_)?<>6WYL"#=_P 7][YFHGKLFG4+8>3K
M?)9&JE>6>NJ.L\[05.-P[%F&F#!56%HQ8DPEF+&6^7O>;FS9(5M+LQWUJHH/
M&KX@ \O$4@G[7#GY]13O_M!RMO,S75J)+*Y8U/A4\,D^?AL"!]B%!\NJSJG_
M (2)T[5$[4?\P*:"D::5J6"I^*Z551#3EV,$4]5%\C:.*IFCBL'D6&)78$A%
M!T@;+]X0T&K: 6IFEU3^7TYI^T_;T#3[!BIT[J0M<?XM7^?U _P#HZ7QK_X2
MZ?"3J;.X[<_>>_\ L[Y,5^+JEJ8=KY3['K/K6N:-F>#^,[>VO49'=^1\$@1O
M%_>*.DFTLDT$L;E/8:WKWSYGW")H-KA@LD84U"LL@^QFH@^WPZCR(.>A'L_L
MGRW82B;<Y9KUU/PFD<9^U5JY_P"<E#Y@C'6R'M/:6UMA[:P6R]D;;P6S]H;7
MQE)A-M[6VQB:#!;>P&'Q\*T]#BL-AL7!2X_&X^C@0)'##&D:*+ #W#-Q<3W<
M[W-T[R7#L69F)9F)XDDU))\R>I@@@@M85M[9%CMT4!54!54#@ !0 #T'2@]L
M].]4!_,S_A/!\4?FC\D.P/DOO#MOOC8^Z^S9\%6[IP&S<CL:7;QR6$V_BMM"
MMQ8W%LS,Y*A^^QN&@:2-IYHUGUL@5&$:RURW[P;_ ,M;+#LEM;VDMO &"LX?
M51F+4.EP#0DYH,<?7J*^8O:78N8]XEWFXN+J*>8J65"FFJJ%J-2$BH \SG]G
M5YO7VQ]O]8[!V1UKM.&HIMK=>[0VUL?;5/5U,E;5P;?VGAJ+ X:&JK)KS5=1
M%CL?&KROZI&!8\GW%MY=37UW+>W!!GFD9V(%!J<EC0>62<=29:6T5E:Q6< (
M@BC5%J:G2H"BI\\#CT^9O"XC<F&R^W=P8VBS.!S^,K\+F\/DJ>*KQV5Q&5I)
M:')8VOI)E>&JHJZCG>*6-P5>-R""#[:BEDAD6:%BLJ,&4C!!!J"#Y$'(Z=EC
MCFC:&50T3J0P.0010@CS!&#UK';G_P"$IOP<R^X<SE-O]V?)7:6%R&0J:S&[
M8ILQUYF*3 4M1(98\31Y/,;"J,O6T5%J\<+U4L]3X@OEEE<-(TWP>_7-$<*Q
MS6ME)*  6(D!8^I DH"?.@ KP &.H7F]C>69)6>*YO(XR:A08R%'H"4J0/*I
M)IQ).>K7/Y;?\K[H_P#ED;-[)VKT]NSL7?%7VMN+"9_=>X>QLA@JBMT[:Q];
MC\#BL71;<P6 QM%04*Y2KE9FCEJ)I:EM<A1(HXP#SISSNG.]S#<;C'#$MNC*
MBQA@.X@L269B2: <0 !PK4D=<G\E;;R7;S0;?)-*T[AF:0K7M!"@!54 "I/F
M23QI0"RCV"^ACUK'[]_X2R?"C>N^]W;RI.[?D=M:BW7N?,[D7:^(R/6]3C<$
MN:R,^2DP^*J\GL"KKVQ]"]2T5.:AYIEB50[R,"S3=:>^W,UM:1VS6ME(T:!=
M1$@+:12I D J:5-*"O #J&+KV0Y;N;J2X6YO$61RVD&.BU-: E":#@*U-.->
MMC'J?K3:_2_5G6O3NR(:RGV7U/L#9O6FT(,A5&NKX-K[$V[CMKX"&NK2D9K*
MR/$XJ%992J^1P6L+V]PYN%[/N5_/N-U0W-Q,\CT%!J=BS4'D*DT'4NV-G!MU
MC#M]M46T$21I4U.E%"K4^9H!GI?^TG2KJL7^95_*LZ)_F>8/J?&]P[N['V-E
M.FLGN^MVAG^NJ[ 05+46^Z;;L&Y\3E:+<F!SU#5TU;+M+&S1R(D4T+TU@Q61
MU(XY*Y\W7D>6X?;HX98[E4#K(&I5"VD@JRD$:V'F#7Y#H%\X\C[7SI% FX23
M1/;LY1HRM:.%U AE8$'2I\B*?/I"_P MO^3=\=?Y9N[^Q]_]5[V[1["WAV1M
MO&[/J\KV-6[9:/![:H<FN:JL?AJ+;&W<!#KR^4IZ:2HEJ#.P%)$L7C!D\BKG
M3W'WGG:WAM+^*"&WA<N!&&[F(T@DLS<!4 "G$UKBB7D_V\VCDRXFNK&2>6XF
M0(3(5[5!J0 JKQ-*DUX"E,UMT]Q[T/ND[N_:^+WOM+=&R\W]P<+N_;N;VOEQ
M23"GJSB\_C:G%5_VLY2005'VE6^A]+:6L;&UO;UO/):W$=S%3Q8W5A7A52"*
M_F.F;B!+F![:2OAR(5-.-&!!I^1ZUA)?^$GOPP,DAA^1?R>CA+N8DEJNJ99$
MC+'0DDJ]<PK*ZK8%@B!CSI'T]S@/?WF6F;.QK]DO_6SJ%C[%<NUQ>7M/MB_Z
MU]8_^@3SX:_]Y'?)O_J=U7_]K[WO_7]YD_Y0['_JK_ULZ]_K%<N_\IE[_P!4
MO^M?7O\ H$\^&O\ WD=\F_\ J=U7_P#:^]^_U_>9/^4.Q_ZJ_P#6SKW^L5R[
M_P IE[_U2_ZU]6Y?RV/Y772G\L?:G:&VNH=Z=D[ZF[:S^WLYN;+]C5FW9IX%
MVK09*@PN/Q-)MO;^ I*:GA&9JI)7D$TLKR@:@J*/<?<Z<];GSO<03[C%#$+=
M&51&&_$06)+,Q/ 4X 4^?0]Y.Y)VWDN">';Y)I3.ZLQD*_A!  "JH'$UXDUZ
M!O\ F/?R4/CE_,K[7V1W-VCV)VYU]O39G7L/6(DZ]K]K?PS,[7Q^Y,_NK#)6
MT&YMM9T4]?C,MNS)GS0/'YHZA5<'Q(?9CR9[F;SR582[;8PV\UM+-XOZ@:H8
MJJFA5EP0BX/"F.)Z+N;_ &WVCG*^BW&]FN(KF.'P_P!,K0J&9A4,K9!9LCC7
M/#JO'_H$\^&O_>1WR;_ZG=5__:^]C#_7]YD_Y0['_JK_ -;.@G_K%<N_\IE[
M_P!4O^M?7O\ H$\^&O\ WD=\F_\ J=U7_P#:^]^_U_>9/^4.Q_ZJ_P#6SKW^
ML5R[_P IE[_U2_ZU]6$_%#^0I_+A^)>X:#>N$ZMS7<^_,//#4X3=_P @\W0=
M@S86J@D,T5;C=IX_![8ZXBR<$XCDAK&PCUE+)$K02Q-J+!#?_=?G/F"$VTLZ
MVUJPHR6ZF/4/0N6:2GJ-=#7(/0KV+VNY0V&87,4#7-TIJKSD2:3ZA0JQU]#H
MJ*8(ZN8]QOU(G7O?NO=:TO;G_"7KX5=I]J;_ .S(>Y?D7LV+?^\,[O.IVGA,
MKU[78G!UFY,E/E\GCL-6YO8E?EOX9'7U<OVPJI:F:*$JCR2LI=IJV_WRYFL+
M"&R-M9R&&-4#L) 6"B@)"R 5H!6@ )X <.H;O_93ER^OI;T7%Y&)9&<JIC(4
ML:D E":5)I4D@<2>/6PATSU-L[H;J3K/I3KVEJJ+8W4^Q=K=>;3IZZI%;D%P
M&T<-1X/&R9.M$</WV3J*:B62IG**9YV=R 6]Q%N6X7.Z[A/N=X0;JXE:1Z"@
MU.Q8T'D*G \ACJ6-NL+?:["';;0$6T$2QK7)TH HJ?,T&3YG/0E>T72SJO+^
M8S_+:Z4_F6]7;/ZS[BW#OK9YV#O [SVKNKKZOQ-+F:&LJ,94X?*8ZJI<_B<W
MB*[&92BG4N&@$T<L$;1R*!(D@PY-YTW/DJ^DO=N2*3Q8]#K("5(!J""I4@@_
M.E":CA0)<W\G;;SE91V6X/+'X4FM6C(!!I0@A@P((^5:@4/&I>_Y</\ )0^.
M'\M3M7>W<O5W87;W8.]]Y]?5'63S=AY#:O\ "L/M7([CV]NK+QT.-VSMC!>?
M(9'+[2QQ,\\DOBCIRL:KY')-^<_<S>>=;"+;;Z&WAM8IO%_3#5+!645+,V '
M; I4G/ =%7*'MQL_)M])N-C-<2W,D7A_J%:!2RL:!57)*KDUI3'$]7(^XXZD
M+K5NRW_"47X3UN5R=9C.^_DQA<;5Y"MJ<?AX\AUI71XFAGJ9):3&1UM;L!ZR
ML2@@=8A+*QED":F)8GW.D?OWS,L:J]I8LX !-)!4TR:"2@KQH,=0E)[%\ML[
M,EU>JA)(%8S0>0J8ZFG"IZ;_ /H$\^&O_>1WR;_ZG=5__:^]W_U_>9/^4.Q_
MZJ_];.J_ZQ7+O_*9>_\ 5+_K7U[_ *!//AK_ -Y'?)O_ *G=5_\ VOO?O]?W
MF3_E#L?^JO\ ULZ]_K%<N_\ *9>_]4O^M?5H_P#+4_E&]$?RQ:WMG+=2=@=J
M;_R_;]+M+'9ZJ[&K-JR4V,QVS9<[4XV##4>V=LX#1/55.XIVJ)9Y)]2I$L:Q
MZ7,@%YU]P=UYX6WCW"&"&.W+E1&&R7T@U+,W ** 4\ZUQ0;<G<A;7R6T\EA+
M/+)<!0QD*X":J4"JO$L:UKY4IYA=_,0_D;_&[^8UW5A>]^R^T.Z]A;RQ6Q<7
MU_44NQLQMFIP%?AL'D\OE,5-'CMV[;W ^(JH9L[4B5:.2&FF+"0Q"9I9)5W)
M_NCO7)NV-M5E!:RVS2F2KA@P+  Y1EJ.T4J"1PK2@"'FWVSV?F_<EW2\GN8K
MA8A'1"NDA22,,K4/<>% >-*U)L9^(WQ6ZJ^%7Q]Z_P#C=TS3Y=-B=?4N46CK
M]QU=+D=SY[*9[-9#<.=W!N3)45!C*:NR^5R^4FD8QT\,,,>B&&..&*.-0=S#
MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140699036908200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 14,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UNITEDHEALTH GROUP INCORPORATED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-10864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1321939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">UnitedHealth Group Center, 9900 Bren Road East,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minnetonka,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">936-1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UNH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000731766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>unh-20220414_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="unh-20220414.xsd" xlink:type="simple"/>
    <context id="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2022-04-14</startDate>
            <endDate>2022-04-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM180L2ZyYWc6NWI0NjgzZGQzNTFiNGYwYjk3ZmI1YWY3NzM0MmNjYzQvdGFibGU6ODFkOTIzZjJmMDFjNGI3MWIwZjVjMTM5MmUzNGI0YmEvdGFibGVyYW5nZTo4MWQ5MjNmMmYwMWM0YjcxYjBmNWMxMzkyZTM0YjRiYV8yLTEtMS0xLTI0NTgy_1f39ed76-9a92-4c29-be2a-152bfae4e568">0000731766</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM180L2ZyYWc6NWI0NjgzZGQzNTFiNGYwYjk3ZmI1YWY3NzM0MmNjYzQvdGFibGU6ODFkOTIzZjJmMDFjNGI3MWIwZjVjMTM5MmUzNGI0YmEvdGFibGVyYW5nZTo4MWQ5MjNmMmYwMWM0YjcxYjBmNWMxMzkyZTM0YjRiYV8zLTEtMS0xLTI0NTgy_d03301a8-9d6c-4622-a736-54d3ee32928e">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg3_5b3d6f6f-bd41-491a-9648-73e47c0c42aa">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8yNTc_983e7115-1eaa-489c-a36e-8432b105bde9">2022-04-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg0_d80100cb-d9bb-45cf-b5dc-e81ec0fd5140">UNITEDHEALTH GROUP INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTAtMS0xLTI0NTgy_b723c78e-33a9-4729-ad6f-5c359977aa0a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTItMS0xLTI0NTgy_25eecbb2-2b98-480c-b641-796b63ecd3db">1-10864</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTQtMS0xLTI0NTgy_9bb48c38-16d8-4abe-8c02-75244012a1bf">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6YjQwY2VhZDYwNzNkNGYyNGFhYzc1ZWMzNjM2MTVhNTkvdGFibGVyYW5nZTpiNDBjZWFkNjA3M2Q0ZjI0YWFjNzVlYzM2MzYxNWE1OV8wLTQtMS0xLTI0NTgy_b25ba955-33e3-43d3-9d5b-c00c9cd4a459">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTAtMS0xLTI0NTgy_d1244ec9-8d29-4c86-8276-18ce42fd6a93">UnitedHealth Group Center, 9900 Bren Road East,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTEtMS0xLTI0NTgy_4e549972-f60e-4b90-bb73-b87292df6b06">Minnetonka,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTItMS0xLTI0NTgy_0c84dd60-cffd-40d7-b93c-17774fd21db5">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MWUwMTEzMzZhZTcyNDAzYTk1YzIxZjAwMTI4ZWY4ZjcvdGFibGVyYW5nZToxZTAxMTMzNmFlNzI0MDNhOTVjMjFmMDAxMjhlZjhmN18wLTMtMS0xLTI0NTgy_765b8c53-f5fb-4cdf-b258-20b08d65a225">55343</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg4_78a23195-45d9-46a3-9e5c-8d57705a21d6">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg5_97af04e8-4164-4771-a1a4-a0201f65fe7c">936-1300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjkw_4e7eef3e-099f-4d9c-9f50-0f61621e9205">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg1_79506bb7-90da-48b0-a3f3-3629b0b8facd">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjg2_f591d502-a81e-45b2-b2bb-feb106222a26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjkx_53c1b9b9-f87d-4287-9513-ea61cf82bbc8">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTAtMS0xLTI0NTgy_701e197a-0ede-4758-9538-9360cc6b47bf">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTItMS0xLTI0NTgy_88485718-76ab-4745-9726-d51463cfe46b">UNH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGFibGU6MGVjZWRkMjY4NDBiNDU3OTkzYjZjNmFhNjM2ZDliYzMvdGFibGVyYW5nZTowZWNlZGQyNjg0MGI0NTc5OTNiNmM2YWE2MzZkOWJjM18xLTQtMS0xLTI0NTgy_a0d15fc0-e87b-495e-83c2-7943fa6e039f">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkY2Y2MmRmZjY2OTRmOWM5NjBmMjg1ZWUxZWUzZWMzL3NlYzpjZGNmNjJkZmY2Njk0ZjljOTYwZjI4NWVlMWVlM2VjM18xL2ZyYWc6YjAyYzBjN2ZlOTg1NGMyZWFjOTVmMGVkMWY4OWE2NDgvdGV4dHJlZ2lvbjpiMDJjMGM3ZmU5ODU0YzJlYWM5NWYwZWQxZjg5YTY0OF8xNjky_8c77cb27-6265-4c02-ba8d-1a16405003b6">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$-)V3MJ^A'0L JD2J;+A4B=S QU)I")#F0JC=G -2_%Q\?L10GB3$]Y<0OC
M(T8F:;PLGV2XAG?EN9UV$Z'IY#2=2V@6](.,0QA]?,6#_1P[SX8K-@&NX7O=
M1A?!Z^9XW4OP!F&HF-;UXPW)YO^+*,TAKO@JN&'A(Z.1V9!O2J8)&4*[F:J3
M;M=UR9UB@LPDA0E(M:DC;?#<PDG=3[5B:$LP&A=R*TH=%I=[YD(P(\4;1?%.
MC-[[%%X^6Z9*OG,1E/9RA>;S!$,KS-_S/X4VE=K0B/S%D[-3N$*QU6HT&QA;
ML6AXN.UG61S AN<\"B[0;6'>[!4+AX?[_9,,H$^F&RDP1ZD0Z3;:,&]=%R,J
ME@L/]_D?BAL#\V@HXS@5!T?1I52XT(I&FF%(Q;K@X=X]EQ$/N.%B39YA>"M.
MHU(>7*62IU@%/-S"IXI=!= ]#.;7?N_!1,@4>5FMSN0/UZLD*U8$#S?P_Y&-
MM4Z!K!(0EZT$+-8$#[?P!3>P=LH5\?S?EK^3.0M2&&^[4B9<R8Y/6.KF1@9O
M=?+KM>N1A"KR3J,40_4+Y_=QJUXH&MHA-]_%2UDZX"H$7B>/&$CA\3[NQ\=.
M(J./8$/%FIW=P54(3?Z<8[L@_V1??Y&UCV*FUK:+8"W>PI(,*4FH*$UFA6#5
M /,+9_=Q8SZ@V7V! F<=P[C_(-]9.10NY<+?3<.[:;<QLL+J_8JM/4S(,)N4
M#Q%=E_+@ F<[R3DY*=I3]S.U:=$D8BL0<J]OP*C5_B"[+QB99(?'I31P%,UN
M-W#X9\I^ .]74IICP9Y'\Y\3^O\"4$L#!!0    ( $PPCE2?H!OPL0(  .(,
M   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A
M7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*Z
MW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MU
MIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$
M>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5
M=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K
M3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$
M"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T
M08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+
M?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.
MZ%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&
M^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA
M>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7J
MEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-
MY0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\
MC@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( $PP
MCE27BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] A
MB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:
MU;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]
MVR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::
M1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$
M%     @ 3#".5*K$(A8S 0  (@(   \   !X;"]W;W)K8F]O:RYX;6R-4=%N
MPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%C:^?VZH:TE[VE-S9NMQ=
M%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6S
MU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5RMQD
M)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"%'*7?
MZ/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:PIJ+U
M$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;<L@F:NJF*9ZC#GA3#O9&3R54&*!\
M4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0    ( $PP
MCE0D'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.U
MD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.
MGV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S
M9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H
M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( $PPCE0'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 3#".5,B5E+7N
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ 3#".5)E<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !,,(Y4&Z8$ETT$  !:$
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ 3#".5)^@&_"Q @  X@P   T              ( !D P  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !,,(Y4EXJ[',     3 @  "P
M        @ %L#P  7W)E;',O+G)E;'-02P$"% ,4    " !,,(Y4JL0B%C,!
M   B @  #P              @ %5$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ 3#".5"0>FZ*M    ^ $  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 3#".5&60>9(9 0
MSP,  !,              ( !FA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  Y!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="unh-20220414.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.unitedhealthgroup.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="unh-20220414.htm">unh-20220414.htm</File>
    <File>a2022q1exhibit991.htm</File>
    <File>unh-20220414.xsd</File>
    <File>unh-20220414_def.xml</File>
    <File>unh-20220414_lab.xml</File>
    <File>unh-20220414_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "unh-20220414.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "unh-20220414_def.xml"
     ]
    },
    "inline": {
     "local": [
      "unh-20220414.htm"
     ]
    },
    "labelLink": {
     "local": [
      "unh-20220414_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "unh-20220414_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "unh-20220414.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "unh",
   "nsuri": "http://www.unitedhealthgroup.com/20220414",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20220414.htm",
      "contextRef": "ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.unitedhealthgroup.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20220414.htm",
      "contextRef": "ib9b13d1739ae4b4c9a8b5518077dba42_D20220414-20220414",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000731766-22-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000731766-22-000016-xbrl.zip
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MYR,-8]>VO/2)[.'\XW0)N@D_+*YXY4J*U.#/B8,QIT9A339P@(:O^"C9]^W
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M'R[<R';'^+%#Z'=J)S'S!@8D2$+B =5:L*X13 [4#WV8I!Z!12*0W3$90,
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M[8GXCD $G,.W];RP3PLVIZN?K3::5C'%.5FX]G2;LMJXK.HNE_JTW3W?)*,
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MZI)R F5]-W!IE^U$B?3I@^MCJ1$&'83A Y'P+.&_JI+>:79=^I+>0UOJ;5:
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MYNDYL5]"IHJ+O;ZAV#]3UZ'Z8B]$X3E1T)HD"DT]K3PO9@.F/;M&L\''X;(
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M:H4%NA0/\3;)GAP<6+Q1,KPRM"YY$KRW@YD3H->>CXU/@21:0_*8+(3Q:4Q
M)_DP5<P!Q*';3[CC%@?+4@QV,!H%/@\<AH$'S(Z.G9*J^QG>:U-2M(Z@XHY4
M-*1N^^A)Y-I34>U)FJF0%L%77<ULR/'RE1];_H.+>L\:!3";ORT,F<7)WUK*
M:=TR+D3CJ=03I\CKJ?3C#ZK6_J!*JJXTQ >[M[X3F"D$B"08$'>/6JA99WYO
MVSUQS%Z"3!U5D*FL'GJK=96?#N'_\"M8O4HJI!S)<JS <(\6K_;.N"EI>D]0
M<??PNFL**NX,\)/@%0:&\*K=61H8S@%$5/69&B"5+URPM](>8I;;S/)T<PTL
M[^JXB'QRIB8VAV,<6U/501F9\I8)T\;121$H_U+&3=93VR9WFY)[6)'SW%$3
M-2M25&1M.P>]:632M\L2-XM,:?Y3UG940;5QA0KISRD<=<^)T&:9LK>*K'3$
M#<ARA.H*0I5.AJ*'M&,V])F^<57/ANXY7-M_:+VZ\%7M,T^F;!S=QVH"E8_O
MHIT^E35T[EB@J<J=)5[>RN)RJ^ZT/'^!L7 SICU_70RKOQVJ'ERYNXR%*R8O
M],Q9"FBFK&BXY.6'7E./U(V(1?S Y[>^!JYO^:P/S8A:41)2F5RO_"R"(8+$
M<TB?PE;P(Q?D%Q[D^@1GPN+M.)!(/XGA 3&Q\$E1TH]B-P:#0P9!*)$ YI'
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M5A+&0VAMUI$HA,GL4\CEYR 4*2H $DLUX$[C]WFV6&R\-?MJOO<!+&_"9Y]
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M+$TW>FIE\\LA<2?I]\-,IL@C:2RA4NRLT?5*T=6H'E6/JVBO/XB2,3#=O,Y
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M)VT&@73CU@P\Q\#T>Z#;A.L*Q<PB IQPCV*/>AX.A$<4@U+*J+%FX+ECUZG
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M,C R,C T,30N>'-DU55=;YLP%'W/K_!XG@,DM"2H2:6UJC0IVZ2N5?LV&;B
M5;"I;9KTW]<VH)0TW8JTATV*%'/O.<?WP[X^.]]5)7H"(2EG*\>?>@X"EO"4
MLGSEW-Y<X85SOIY,SCYA?/_E>H,N>=)4P!2Z$$ 4I&A+58'N4I /*!.\0G=<
M/- G@O':DBYX_2QH7B@T\V:S0Z^(DH2<+&<>X""-8QR$)R%>S!<Q/@G#=+F(
M/3^+X7,>S8,PR,*0X+D?SW'@91XFD/HX2;6#^*<Q.<VLZ$Y&,BF@(D@GQF2T
MDRNG4*J.7'>[W4ZW\RD7N3OS/-^]_[;Y::%.ARTI>QB@=[$H>_S<->Z82.CA
M#2L&Z(9179 "2*F*7/"FGB:\<DW:7N '#B)*"1HW"JZXJ"XA(TVI5D[#'AM2
MTHQ"JDM?@BGN /#*K8C(07TG%<B:)#!F]_4$(5,<6M5<*,2.:G35\9?+I;LS
MZ3JH+>:&)T39$_)N=2P>FR7V9[I-TYU,'?=#VPZ%*).*L 3&[*V_<,_[&S'L
M6STNAIXW/@8K)B&9YOS)38&:SOF/P?$ Y/L$L\3M<K@S88PKJV$LG:VN*<MX
M:] F$W[4YW -67^'WER,(P?%_D5$)(*7?SA5;BUX#4)1D*\OE14H!&3F4A2X
M/[J_2A)/=2 ]XHW^L _&[6H*E)M](CU7/=>:*W472FA+\P_G70L8F[>F2#T_
M;)O_]_13R,:FKRE4C\'QR1OVC?8CFJZ<"Z[?0P<9V^WUUP\,6;MWR^IE>^%]
M1&M/OSGZA_#^#<7(LL[<0^R!2B,A_<'6=GW8XH[<07Y#3$B9-.5XWK"H1VF=
ML:]B-V#<X81IOU]-(6MHQ]MZ\@)02P,$%     @ 3#".5,B S.GK!P   3D
M !0   !U;F@M,C R,C T,31?9&5F+GAM;-V;77/;NA&&[_,K5/6V:^&;@"?.
MF=1).I[FG&02G\F9WFCP*7%"D2Y)Q?:_[U*V$MN23U*#:6?D"YFB0.R[^X#
M @2?_W*UJB9?8MN537TRI4=D.HFU;T)9+TZFOY^_ 3W]Y<6S9\__ O#'WS^\
MG;QJ_'H5ZWYRVD;;QS"Y+/OEY%.(W>=):IO5Y%/3?BZ_6( 7FXM.FXOKMEPL
M^PDCC#W\M3WVWDK#2 01G -1R (TUPYD402C':')Q;\MCKDH1"H*"YPZ#H(D
M C8&"C[@#Y8J9U7:5%J5]>?CX</9+D[0N;K;?#V9+OO^XG@VN[R\/+IR;774
MM(L9(X3/MJ6GM\6O=LI?\DUI:HR9;7[]6K0K]Q7$:NGLCU_??O3+N+)0UEUO
M:__- )H/_=<+[ZJ1LYL?L6A7'G>;Z]\VWO8;/-]U8?)HB>$;;(O!< HHPV@>
M775A^N+99'(3.=OZMJGBAY@FMX>_?SC;55K6_2R4J]EMF9FM*E2\J:&_OH@G
MTZY<751Q>V[9QO2H^JW+@R@YR/GK4-LL6],2A;1^[2+@V5@/#7Q$C?MJS]?\
MM2X(,=EUU8^H>+?N4?4V*UN.&>"=JD=0NZD(5G'E8CNFU'OUWM&Y%?E0X5#E
MNBZQ^UQ&6_7+1=NL+XY\LYIM=)XV7WY$W[I>PM"I$D'%1L?-=7?L(^@2S6 0
MW^+7VXL'$QE*XE4?ZQ##=%*&DVD9F;:2&9ZTIR)$K57BDA@C'/4J%&1^4\6@
M::NJ:OR]&JNA?VN^FJFLB]7F[#S$<KX=<,[JU+0K>^M,/.OCJILK&@CU1H%B
MT8,P*8!+Q("F3'O&%764[$+MMHVDB_YHT7R9H1TDR^B_Q7 (-X<W:+^CX";:
M>9Z=8]FYU"FY(@K@A&D0*B:P04C@RA0J>8K#81C-D\'B?>7?6LK+=NO#[6WS
MQ/MJ2 9^ L6^&2& -W10_G32M"&V)U,R!LCWL2V;\+H.KS SFB>I>< N JQV
M#(1#52YR DPY133^":='(WK/] &A?7I(=QG3',:OZ[[LKS_$1=GUK:W[W^PJ
MSI6A1!-T3"IA06C,3QT-$I34,DG/"FR&V8CW63X PMD!W07,\@&?X=RGO6C:
MC9,?>VQTI\VZ[MOKTR;$N5;$Q<@3I$)2G*QPG*P$G*PPZ6R0C$O*\X>;'Q!R
M,/C'"_=N:^#YK>%-6<7?UD-DYBXHAHE. $(=#B\R1C#.2#">AQ2,*FQ1C(3^
MF]6#X?S$0.Y"%?E0S^W564 WRU3>S*MOA171$(]Y CBC(PBB#!B5' 0I"7.*
M)EVDD0@_(N%@<(\1XEWV,I_]RQ#:V'6W_P9WZ3SAT$*IDR"B=9A4D (,'=9&
M'"/*4>-M&NO.WF/^8)CGAG:7MQJ-]RD>OFO/F\MZSIB1CC*!(TG )NBE!.U0
M(?8[TB="8Z)CW>4[Q@^-]1/#NDNZ&(WT)H=XU[YOFR]E[3&A=)QR3"* >1I
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M]DR]FB8RFWXJY7DQ5WE/2)W\+A:+.UE>Z6^6']-4EM.0I"1*(@80\1%  <6
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M*JO0<)@)YZ"PQ_1@X>"P>YN!P&"T?0A8KYI_+N8LRZ>$<2$C20"#$*N206)
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MG-WE6EO:[ASKFKE_F<OR.LNO_UD6]]7->3&_9?GCE$041TK4(!%4JF(\08#
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M+W.I7KU[L7XG6_ZCK7<O_@=02P,$%     @ 3#".5+LUSLM[!P  )CL  !0
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M_P)02P$"% ,4    " !,,(Y4NM$G&;LQ   5R ( %0              @ $
M    83(P,C)Q,65X:&EB:70Y.3$N:'1M4$L! A0#%     @ 3#".5/[5FXD_
M%    98  !               ( ![C$  '5N:"TR,#(R,#0Q-"YH=&U02P$"
M% ,4    " !,,(Y4"[UWZ'X"  ")"   $               @ %;1@  =6YH
M+3(P,C(P-#$T+GAS9%!+ 0(4 Q0    ( $PPCE3(@,SIZP<   $Y   4
M          "  0=)  !U;F@M,C R,C T,31?9&5F+GAM;%!+ 0(4 Q0    (
M $PPCE0AM[;JN L  #9M   4              "  211  !U;F@M,C R,C T
M,31?;&%B+GAM;%!+ 0(4 Q0    ( $PPCE2[-<[+>P<  "8[   4
M      "  0Y=  !U;F@M,C R,C T,31?<')E+GAM;%!+!08     !@ & (4!
(  "[9      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
